Soichiro Fushimi

454 citations
34 papers · 276 indexed · h-index 11
Topics
Pancreatic and Hepatic Oncology Research (7 papers)Pancreatitis Pathology and Treatment (3 papers)Neuroendocrine Tumor Research Advances (3 papers)

In The Last Decade

Soichiro Fushimi

27 papers receiving 273 citations

Peers

Soichiro Fushimi
Comparison fields: 5 of 67
  • Molecular Biology 111
  • Oncology 70
  • Pulmonary and Respiratory Medicine 53
  • Surgery 50
  • Epidemiology 47
Replace Weiwei Song with:
Weiwei Song China
Yumi Iida Japan
María Soledad Fernández‐García Spain
Regina Gröbmayr Germany
Jiayue Yang China
Marjolein Meinders Netherlands
Yeqi Nian China
Nathan Richoz United Kingdom
Qiuyan Xu China
Sofia Nordling Sweden
Soichiro Fushimi relative to Weiwei Song China Weiwei Song's profile →
Citations per field
00.5×1.5×2.2×
Weiwei Song · 1×
Citations per year

Countries citing papers authored by Soichiro Fushimi

Since Specialization
Citations

This map shows the geographic impact of Soichiro Fushimi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Soichiro Fushimi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Soichiro Fushimi more than expected).

Fields of papers citing papers by Soichiro Fushimi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Soichiro Fushimi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Soichiro Fushimi. The network helps show where Soichiro Fushimi may publish in the future.

Co-authorship network of co-authors of Soichiro Fushimi

This figure shows the co-authorship network connecting the top 25 collaborators of Soichiro Fushimi. A scholar is included among the top collaborators of Soichiro Fushimi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Soichiro Fushimi. Soichiro Fushimi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 0
4 6
5 4
6 8
7 15
8 10
9 2
10 0
11 2
12 2
13 32
14 16
15 1
16 23
17 9
18 11
19 30
20 9

About Soichiro Fushimi

Soichiro Fushimi is a scholar working on Oncology, Pathology and Forensic Medicine and Surgery, having authored 34 papers that have together received 276 indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (7 papers), Pancreatitis Pathology and Treatment (3 papers) and Neuroendocrine Tumor Research Advances (3 papers). The work is most often cited by research in Oncology (70 citations), Clinical Biochemistry (16 citations) and Neurology (15 citations). Soichiro Fushimi has collaborated with scholars based in Japan, United States and Malaysia. Frequent co-authors include Akihiro Matsukawa, Toshihiro Ito, Sakuma Takahashi, Miwa Sato, Mitsune Tanimoto, Teizo Yoshimura, Hiroyuki Okada, Yasuharu Sato, Katsuyoshi Takata and Mikio Shoji. Their work appears in journals such as PLoS ONE, Neurology and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026